Norway says too soon to say if AstraZeneca vaccine causes blood clots

OSLO - It is still too early to say if there is a link between the AstraZeneca vaccine and three cases of bleeding, blood clots and low levels of platelets reported in Norway, the country's health authorities said on Wednesday.

Norway halted the roll-out of AstraZeneca's vaccine last week, following a similar move by Denmark, amid reports of "unusual symptoms" that required hospitalisation for three health workers who had received the shot. One has since died. "Based on the information we have now, we do not know whether there is a link between the serious reported conditions and the AstraZeneca vaccine," Camilla Stoltenberg, the head of the Norwegian Institute of Public Health (FHI), told a news conference.